059210 — Metabiomed Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Metabiomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4,090	9,662	3,600	9,815	22,325
Depreciation
Amortisation
Non-Cash Items	6,190	-3,389	1,334	-636	-2,620
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,138	1,320	394	-3,156	-1,990
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4,862	11,136	9,159	10,217	22,633
Capital Expenditures	-3,314	-2,100	-15,405	-11,494	-11,102
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-6,602	8,424	827	-207	-32,261
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-9,915	6,324	-14,578	-11,701	-43,363
Financing Cash Flow Items	—	—	—	—	20
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	11,403	-16,107	8,734	-1,023	23,410
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	6,288	1,474	3,113	-2,430	3,721